|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, but not IL-6, stimulates Plasminogen Activator Inhibitor 1 (PAI-1) Expression in Human Subcutaneous Adipose Tissue
1 The Copenhagen Muscle Research Centre, Copenhagen, Denmark; Rigshospitalet, The Department of Infectious Diseases, Copenhagen, Denmark
* To whom correspondence should be addressed. E-mail: BKP{at}rh.dk.
Plasminogen activator inhibitor 1 (PAI-1) is produced by adipose tissue, and elevated PAI-1 levels in plasma is a risk factor in the metabolic syndrome. We investigated the regulatory effects of TNF-
and IL-6 on PAI-1 gene induction in human adipose tissue. Twenty healthy men underwent a 3-hour infusion of either rhTNF-
(n=8), rhIL-6 (n=6) or vehicle (n=6). Biopsies were obtained from the subcutaneous abdominal adipose tissue at pre infusion, 1, 2 and 3-hours during the infusion and 2 hours after the infusion. The mRNA expression of PAI-1 in the adipose tissue was measured using real time PCR. The plasma levels of TNF-
and IL-6 reached 18 pg/ml and 99 pg/ml respectively during the infusions. During the TNF-
infusion adipose PAI-1 mRNA expression increased 2.5 fold at 1 hour; 6 fold at 2 hours; 9 fold at 3 hours; and declined to 2 fold 2 hours after the infusion stopped, but did not change during IL-6 infusion and vehicle. These data demonstrate that TNF-
rather than IL-6 stimulates an increase in PAI-1 mRNA in the subcutaneous adipose tissue, suggesting that TNF-
may be involved in the pathogenesis of related metabolic disorders.
This article has been cited by other articles:
![]() |
W. L. Holland and S. A. Summers Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism Endocr. Rev., June 1, 2008; 29(4): 381 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Plomgaard, C. P. Fischer, T. Ibfelt, B. K. Pedersen, and G. van Hall Tumor Necrosis Factor-{alpha} Modulates Human in Vivo Lipolysis J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 543 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bruunsgaard Physical activity and modulation of systemic low-level inflammation J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J. R. Zierath, and B. K. Pedersen Tumor Necrosis Factor-{alpha} Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 Phosphorylation Diabetes, October 1, 2005; 54(10): 2939 - 2945. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |